1. |
Walston J, Silver K, Hilfiker H, et al. Insulin response to glucose is lower in individuals homozygous for the Arg 64 variant of the beta-3-adrenergic receptor[J]. J Clin Endocrinol Metab, 2000, 85(11):4019-4022.
|
2. |
Masuo K, Katsuya T, Fu Y, et al. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals[J]. Am J Hypertens, 2005, 18(7):1009-1014.
|
3. |
Little J, Higgins JP, Ioannidis JP, et al. Strengthening the reporting of genetic association studies (STREGA):an extension of the STROBE statement[J]. Eur J Epidemiol, 2009, 24(1):37-55.
|
4. |
王静, 莫传伟, 陈群, 等.应用Stata软件的Meta分析完成医学科研定量评价[J].中华中医药学刊, 2008, 26(5):947-949.
|
5. |
包爱民, 肖尚喜, 王长江, 等. 2型糖尿病与正常人群中β3肾上腺素能受体基因Trp64Arg多态性表型特征[J].中国糖尿病杂志, 2000, 8(1):13-16.
|
6. |
孙黎明, Iizuka Y, Ishibashi S, 等.中国人与日本人β3肾上腺素能受体基因Trp64Arg突变的比较[J].中华医学杂志, 2000, 80(2):107-110.
|
7. |
陈玉, 周玲, 徐耀初, 等.β3-肾上腺素能受体基因与2型糖尿病关系的研究[J].中国公共卫生, 2001, 17(7):586-588.
|
8. |
李耀明, 梁剑宁. 2型糖尿病与β3肾上腺素能受体基因Trp64Arg多态性的相关性探讨[J].广州医学院学报, 2004, 32(2):60-62.
|
9. |
孙玉茹, 杨泽, 纪立农.β3肾上腺素能受体基因Trp64Arg变异与2型糖尿病的关联研究[J].中华糖尿病杂志, 2004, 12(1):43-44.
|
10. |
修玲玲, 翁建平, 隋昳, 等.解偶联蛋白2基因和β3-肾上腺素能受体基因联合变异与2型糖尿病及肥胖症的关系[J].中华医学杂志, 2004, 84(5):375-379.
|
11. |
惠宗光, 周学伟, 王晓玲, 等. 2型糖尿病人群胰岛素抵抗和β3-AR基因的相关性[J].潍坊医学院学报, 2005, 27(3):173-175.
|
12. |
李利, 孙黎明, 王军, 等.β3肾上腺素能受体基因Trp64Arg突变与胰岛素抵抗相关[J].中国医师杂志, 2006, 8(5):636-638.
|
13. |
姜秀云, 侯新国, 侯为开, 等.肾上腺素能β3受体基因多态性与肥胖和胰岛素抵抗的相关性[J].中国糖尿病杂志, 2007, 15(9):526-527.
|
14. |
李慧华, 杨敏, 余敏, 等. β3-AR Trp64Arg遗传多态性对T2DM患者罗格列酮疗效的影响[J].中国药理学通报, 2009, 25(3):317-321.
|
15. |
孟晓嵘, 骆杰伟, 郑姜钦, 等. 2型糖尿病痰湿证的β3肾上腺素能受体基因Trp64Arg多态性分析[J].福建中医药, 2011, 42(5):7-8, 13.
|
16. |
Zaagsma J, Nahorski SR. Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical "beta 3-adrenoceptor"?[J]. Trends Pharmacol Sci, 1990, 11(1):3-7.
|
17. |
Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene[J]. N Engl J Med, 1995, 333(6):343-347.
|
18. |
Sakane N, Yoshida T, Umekawa T, et al. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients[J]. Diabetes Care, 1997, 20(12):1887-1890.
|
19. |
王瑶, 萧建中, 李光伟.原发性高血压人群胰岛素抵抗与β3-肾上腺素能受体基因多态性的关联[J].中华内分泌代谢杂志, 2001, 17(3):148-150.
|
20. |
Umekawa T, Yoshida T, Sakane N, et al. Anti-obesity and anti-diabetic effects of CL316, 243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats:induction of uncoupling protein and activation of glucose transporter 4 in white fat[J]. Eur J Endocrinol, 1997, 136(4):429-437.
|
21. |
单志桂, 杨新玲, 姚亚妮.如何运用系统评价结果进行临床实践[J].中国循证医学杂志, 2012, 12(3):357-359.
|